DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

LinksSchließen

Referenz

Jensvoll H, Blix K, Brækkan SK, Hansen JB.
Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study.

PLoS ONE 2014;
9 (3) e92011

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: